Yale School of Medicine Dean David Kessler to Chair The Elizabeth Glaser Pediatric AIDS Foundation Board of Directors
Kessler will lead the Foundation’s efforts to improve the lives of children worldwide through pediatric research, training and advocacy. Kessler served as Commissioner of the U.S. Food and Drug Administration (FDA), where he spearheaded efforts to accelerate drug review, improve food labels and curb teenage tobacco use.
“I am honored to be appointed Chair of the Elizabeth Glaser Pediatric AIDS Foundation,” said Kessler. “Even in its earliest days, the Foundation had tremendous impact. It has turned a personal tragedy into a major international organization with tremendous influence, a solid track record, wonderful leadership, and an incredibly talented board. While the Foundation has grown, its passion and commitment toward ensuring better medical treatments for children have remained clear.”
“The Foundation has retained its agility and ability to respond quickly in fulfilling critical needs in children’s health-whether it is preventing mother-to-child HIV transmission, training the next generation of pediatric researchers or serving as a tireless advocate for children’s health issues on Capitol Hill,” Kessler added. “We’re investing in children’s health and we know what needs to be done. This is an incredible time for the Foundation and I am excited to be leading the organization through its next chapter in creating a healthier future for children worldwide.”
The Foundation has also elected Philip A. Pizzo, M.D., Dean of Stanford University School of Medicine, to serve as vice chair. Paul Glaser, who has been serving as chair of the Foundation’s board for the past six years, is stepping into the new role of honorary chair, where he will serve as a strategic adviser.
“When we first started the Foundation, we actively sought out the advice and involvement of great minds and leaders in their field such as Doctors Kessler and Pizzo,” said Susie Zeegen, co-founder of the Elizabeth Glaser Pediatric AIDS Foundation. “They were there for us when our goal was about saving the life of just one child. They were there for us as the Foundation expanded its reach and its mission to do more for more children. And they are there for us today, as the Foundation embarks upon its next chapter. With the dedication, guidance and leadership of Doctors Kessler and Pizzo, I am confident that the Elizabeth Glaser Pediatric AIDS Foundation is going save the lives of countless thousands of children around the world.”
“We are delighted to have Doctors Kessler and Pizzo on board to lead the Foundation into the future. In my mind, there are no better advocates for children’s health.” said Kate Carr, Elizabeth Glaser Pediatric AIDS Foundation’s president and chief executive officer. “We have an aggressive agenda ahead of us as we strengthen our commitment to pediatric HIV/AIDS research, expand our international programs to prevent mother-to-child transmission of HIV in the developing world and further develop our clinical research network studying other serious and life-threatening diseases.”
The Elizabeth Glaser Pediatric AIDS Foundation is the leading worldwide nonprofit organization dedicated to identifying, funding and conducting pediatric HIV/AIDS research as well as promoting global education, awareness and compassion about HIV/AIDS in children. In addition, the Foundation is committed to working on other serious and life threatening diseases facing children through the newly created Glaser Pediatric Research Network. The Network brings together five of the nation’s pre-eminent academic medical centers in an unprecedented collaboration that will accelerate better treatments for seriously ill children, help train the next generation of pediatric clinical investigators and serve as a united voice to advocate policies that improve children’s health worldwide. Since 1988, the Foundation has raised more than $130 million to ensure that children are at the forefront of every scientific breakthrough.